Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

EVALUATION OF THE SAFETY AND EFFICACY OF REBORN LED SYSTEM FOR NON-INVASIVE LIPOLYSIS TREATMENT

NCT05507528 is registered in ClinicalTrials.gov with Lightfective Ltd as lead sponsor.

NCT NCT05507528
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05507528 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
EVALUATION OF THE SAFETY AND EFFICACY OF REBORN LED SYSTEM FOR NON-INVASIVE LIPOLYSIS TREATMENT
Lead sponsor
Lightfective Ltd
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2022
Completion date
November 11, 2023
Enrollment
107 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lipolysis